Roger Lippé

4.2k total citations · 1 hit paper
57 papers, 3.4k citations indexed

About

Roger Lippé is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Roger Lippé has authored 57 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 24 papers in Immunology and 19 papers in Molecular Biology. Recurrent topics in Roger Lippé's work include Herpesvirus Infections and Treatments (28 papers), Cytomegalovirus and herpesvirus research (13 papers) and Toxin Mechanisms and Immunotoxins (11 papers). Roger Lippé is often cited by papers focused on Herpesvirus Infections and Treatments (28 papers), Cytomegalovirus and herpesvirus research (13 papers) and Toxin Mechanisms and Immunotoxins (11 papers). Roger Lippé collaborates with scholars based in Canada, Germany and United States. Roger Lippé's co-authors include Marino Zerial, Harald Stenmark, Ginette Guay, Vladimir Rybin, Andreas Brech, Ban‐Hock Toh, Judy M. Callaghan, Carol Murphy, Anne Simonsen and Jean‐Michel Gaullier and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Roger Lippé

57 papers receiving 3.3k citations

Hit Papers

EEA1 links PI(3)K function to Rab5 regulation of endosome... 1998 2026 2007 2016 1998 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Lippé Canada 22 1.7k 1.6k 1.2k 590 426 57 3.4k
Eiji Morita Japan 29 2.1k 1.2× 1.9k 1.2× 1.5k 1.2× 653 1.1× 498 1.2× 75 4.8k
Juan Martin‐Serrano United Kingdom 30 2.2k 1.3× 2.2k 1.4× 746 0.6× 666 1.1× 514 1.2× 41 4.4k
Duncan W. Wilson United States 26 1.4k 0.8× 1.1k 0.7× 998 0.8× 479 0.8× 153 0.4× 41 2.6k
Greg Odorizzi United States 27 3.5k 2.1× 3.4k 2.2× 656 0.5× 524 0.9× 741 1.7× 47 5.2k
Trevor Sherwin New Zealand 37 1.5k 0.9× 830 0.5× 1.9k 1.6× 159 0.3× 675 1.6× 85 5.1k
Judy M. Callaghan Australia 22 1.8k 1.0× 1.4k 0.9× 393 0.3× 426 0.7× 418 1.0× 29 3.0k
Kiyotaka Hatsuzawa Japan 30 1.9k 1.1× 1.4k 0.9× 315 0.3× 356 0.6× 264 0.6× 59 3.2k
Jane C. Stinchcombe United Kingdom 31 1.5k 0.9× 1.3k 0.9× 454 0.4× 3.0k 5.0× 348 0.8× 42 5.1k
Jaakko Saraste Norway 32 2.3k 1.3× 2.2k 1.4× 306 0.3× 331 0.6× 361 0.8× 60 3.8k
Nicholas J. Buchkovich United States 16 1.5k 0.9× 944 0.6× 618 0.5× 293 0.5× 251 0.6× 23 2.3k

Countries citing papers authored by Roger Lippé

Since Specialization
Citations

This map shows the geographic impact of Roger Lippé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Lippé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Lippé more than expected).

Fields of papers citing papers by Roger Lippé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Lippé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Lippé. The network helps show where Roger Lippé may publish in the future.

Co-authorship network of co-authors of Roger Lippé

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Lippé. A scholar is included among the top collaborators of Roger Lippé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Lippé. Roger Lippé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grandvaux, Nathalie, et al.. (2024). Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles. Journal of Virology. 98(7). e0085024–e0085024. 1 indexed citations
2.
McInnes, Iain B., Koji Kato, Marina Magrey, et al.. (2023). POS1541 LONG-TERM EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: 3-YEAR RESULTS FROM THE PHASE 3 SELECT-PsA 1 STUDY. Annals of the Rheumatic Diseases. 82. 1137–1138. 1 indexed citations
3.
Bonneil, Éric, et al.. (2023). RNA helicase DDX3X modulates herpes simplex virus 1 nuclear egress. Communications Biology. 6(1). 134–134. 12 indexed citations
4.
Baraliakos, Xenofon, et al.. (2023). AB0947 EFFECT OF UPADACITINIB ON REDUCING PAIN IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS AND INADEQUATE RESPONSE TO BIOLOGIC THERAPY. Annals of the Rheumatic Diseases. 82. 1691–1692. 1 indexed citations
5.
McInnes, Iain B., Koji Kato, Marina Magrey, et al.. (2021). AB0523 LONG-TERM SAFETY AND EFFECTIVENESS OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS AT 56 WEEKS FROM THE SELECT-PsA 1 STUDY. Annals of the Rheumatic Diseases. 80. 1288–1289. 4 indexed citations
6.
Richette, Pascal, Ennio Lubrano, Edit Drescher, et al.. (2021). POS1030 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY BASELINE SKIN SEVERITY: A SUBGROUP ANALYSIS OF TWO PHASE III TRIALS. Annals of the Rheumatic Diseases. 80. 786–787. 1 indexed citations
7.
Coates, Laura C., Ana‐Maria Orbai, Valderílio Feijó Azevedo, et al.. (2020). Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire. Health and Quality of Life Outcomes. 18(1). 173–173. 39 indexed citations
8.
Lippé, Roger. (2020). Intracellular transport of Alphaherpesvirinae. Virologie. 24(4). 210–230. 3 indexed citations
9.
Lippé, Roger, et al.. (2019). Analysis and Sorting of Individual HSV-1 Particles by Flow Virometry. Methods in molecular biology. 2060. 289–303. 7 indexed citations
10.
Gaubitz, M., et al.. (2019). Etanercept in der klinischen Routinebehandlung von Patienten mit rheumatoider Arthritis. Zeitschrift für Rheumatologie. 78(6). 552–558. 1 indexed citations
11.
Lippé, Roger. (2014). Characterization of Extracellular HSV-1 Virions by Proteomics. Methods in molecular biology. 1144. 181–190. 5 indexed citations
12.
Lippé, Roger, et al.. (2011). In vitro nuclear egress of herpes simplex virus type 1 capsids. Methods. 55(2). 153–159. 8 indexed citations
13.
English, Luc, Magali Chemali, Christiane Rondeau, et al.. (2009). Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nature Immunology. 10(5). 480–487. 356 indexed citations
14.
Rubino, Mariantonietta, Marta Miączyńska, Roger Lippé, & Marino Zerial. (2000). Selective Membrane Recruitment of EEA1 Suggests a Role in Directional Transport of Clathrin-coated Vesicles to Early Endosomes. Journal of Biological Chemistry. 275(6). 3745–3748. 134 indexed citations
15.
Simonsen, Anne, Roger Lippé, Savvas Christoforidis, et al.. (1998). EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature. 394(6692). 494–498. 925 indexed citations breakdown →
16.
Stenmark, Harald, et al.. (1998). Two distinct effectors of the small GTPase Rab5 cooperate in endocytic membrane fusion. The EMBO Journal. 17(7). 1930–1940. 90 indexed citations
17.
Horiuchi, Hisanori, Roger Lippé, Heidi M. McBride, et al.. (1997). A Novel Rab5 GDP/GTP Exchange Factor Complexed to Rabaptin-5 Links Nucleotide Exchange to Effector Recruitment and Function. Cell. 90(6). 1149–1159. 486 indexed citations
19.
Michaelis, Christine, Bruce W. Banfield, Samantha Gruenheid, et al.. (1992). Toxin resistance and reduced secretion in a mouse L-cell mutant defective in herpes virus propagation. Biochemistry and Cell Biology. 70(10-11). 1209–1217. 2 indexed citations
20.
Lippé, Roger, et al.. (1991). Adenovirus infection inhibits the phosphorylation of major histocompatibility complex class I proteins.. The Journal of Experimental Medicine. 174(5). 1159–1166. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026